A higher dose of either drug meant a 6.6% weight drop versus 3.5% for a lower dose. Those taking the drug for obesity experienced a 5.9% decrease in weight versus 3.2% for diabetes treatment.

People considering weight-loss medications might wonder which one works best, and first-of-its-kind research points to an answer. A new study published in the New England Journal of Medicine ...

But it’s worth mentioning that when Wegovy was tested at a much higher dose of 7.2 milligrams, people lost around 20.7% of their body weight. That’s a big jump from the 13.7% seen with the ...

T here’s no question that the wildly popular injectable weight-loss drugs help people drop pounds, lower heart-disease risk, manage obstructive sleep apnea, and more.But as more people use these ...

Wegovy and Saxenda are approved for weight loss, and Ozempic and Victoza are for diabetes; all four are manufactured by Novo Nordisk. Women were more likely than men to achieve a 10% weight loss.

Hair loss also correlated with amount of weight lost, as more participants who lost 20% or more of their body weight experienced hair loss than those who lost less than 20% (5.3% vs 2.5%).

Medications that can help you lose weight—like Wegovy and Ozempic—have become household names. But a new study found that the results may not look the same for everyone. The study, which was ...

Both drugs led to substantial weight loss, but Mounjaro's 20% weight reduction, after 72 weeks of treatment, exceeded the 14% from Wegovy, according to the trial's findings.